Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Response to neoadjuvant chemotherapy (regimen and number of cycles administered)
| Therapeutic response after neoadjuvant chemotherapy n (%) | ||||
|---|---|---|---|---|
| Neoadjuvant chemotherapy regimen | OR (CR+PR) | SD | Total | |
| Paclitaxel & Carboplatin | ||||
| 1 cycle | 1 (11.1) | 8 (88.9) | 9 | |
| 2 cycles | 31 (53.4) | 27 (46.6) | 58 | |
| 3 cycles | 54 (68.4) | 25 (31.6) | 79 | |
| 4 cycles | 20 (64.5) | 11 (35.5) | 31 | |
| Topotecan & Cisplatin | ||||
| 1 cycle | 1 (100) | 1 | ||
| 2 cycles | 4 (30.8) | 9 (69.2) | 13 | |
| 3 cycles | 6 (37.5) | 10 (62.5) | 16 | |
| 4 cycles | ||||
| Total | 207 | |||
